Phosphoramidate alkylator prodrugs
US9226932B2 · kind B2 · utility
0Cited by
42References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 10, 2013 |
| Grant date | Jan 5, 2016 |
| Priority date | — |
| Expiry date | Jan 14, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K51/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Phosphoramidate alkylator prodrugs can be used to treat cancer when administered alone or in combination with one or more anti-neoplastic agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.